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Tumor necrosis factor-α (TNFα) is a proinflammatory cytokine implicated in cerebrovascular pathology. The aim of the present study was to
characterize the simultaneous effects of an intracarotid administration of TNFα on cerebral blood flow (CBF) and the ultrastructure of the blood–
brain barrier (BBB) and to determine whether nitric oxide (NO) is a mediator of the TNFα-induced alterations in CBF and BBB. TNFα (2.5 μg/
kg) or saline was infused into the right common carotid artery of male Wistar rats (n = 70). NO production was inhibited with L-NAME (20 mg/kg,
i.v.). CBF was monitored for 2 h with laser-Doppler flowmetry. Tissue samples were taken from the unilateral frontoparietal cortex and prepared
for electron microscopy. The proportion of capillaries with swollen astrocytic endfeet and the lumen diameter of the capillaries were measured.
TNFα significantly increased CBF, which reached a maximum of 190% of the baseline 1 h after the cessation of TNFα infusion. L-NAME
completely prevented the increase in CBF. TNFα elevated the swelling of the astrocytic endfeet from a baseline value of 22.4 ± 9.35% to 64.9 ±
3.16%. The administration of L-NAME before TNFα infusion prevented the astrocytic swelling. These results demonstrate that TNFα increases
CBF and the swelling of astrocytes through the production of NO. Our data additionally demonstrate that the breakdown of the BBB by circulating
TNFα may involve the astrocytic endfeet.
© 2006 Elsevier Inc. All rights reserved.Keywords: Astrocyte; Blood–brain barrier; Cerebral blood flow; Nitric oxide; TNFαIntroduction
Tumor necrosis factor-α (TNFα), a proinflammatory cyto-
kine, is known to be one of the key mediators in a broad variety
of central nervous system diseases, such as bacterial meningitis,
traumatic brain injury, cerebral ischemia and multiple sclerosis
(Arvin et al., 1995; Jacobs and Tabor, 1990; Ledeen and
Chakraborty, 1998; Sharma and Kumar, 1998). TNFα has also
been implicated in the pathomechanism of cerebral malaria and
HIV encephalitis (Gimenez et al., 2003; Sato-Matsumura et al.,
1998). Among a wide range of functions (e.g., the activation of⁎ Corresponding author. Department of Anatomy, School of Medicine,
University of Szeged, H-6701 Szeged, PO Box 427, Hungary. Fax: +36 62
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doi:10.1016/j.mvr.2006.05.007microglia and the regulation of apoptotic neuronal death), TNFα
exerts profound effects on the cerebrovascular system.
Proinflammatory cytokines have been suggested to be vaso-
active compounds that cause cerebral vasodilation and increase
the cerebral blood flow (CBF) in bacterial meningitis (Fassbender
et al., 1996; Park et al., 1999). As supportive evidence, animal
studies have furnished data that topically applied TNFα dilates
the pial arterioles (Brian and Faraci, 1998; Shibata et al., 1996).
TNFα additionally elicits leakage of the blood–brain barrier
(BBB), as demonstrated by the extravasation of sodium fluo-
rescein and Evans blue-labeled albumin in vivo (Abraham et al.,
1996; Farkas et al., 2003). Studies that employed in vitro BBB
models have revealed that TNFα increases the permeability of
the BBB by reducing the transendothelial resistance and by
promoting paracellular and transendothelial permeability (de
Vries et al., 1996; Deli et al., 2005; Hurst and Clark, 1997; Miller
et al., 2005). In order to identify the cellular correlates of BBB
Table 1
The composition of the experimental groups
Experiment Saline/TNFα, i.c. L-NAME, i.v. Survival time n








Saline + 4 h 5
TNFα − 5
+ 5
Saline + 8 h 5
TNFα − 5
+ 5
Abbreviations: i.c.: intracarotid, i.v.: intravenous, L-NAME: N(G)-nitro-L-
arginine-methyl ester.
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(e.g., Lee and Kang, 2004; Miller et al., 2005; Otto et al., 2000;
Trickler et al., 2005), but other BBB compartments, such as the
astrocytes, have received less attention. Nonetheless, astrocytic
injury may have serious implications, given that the astrocytes
play a crucial role in the maintenance and regulation of the BBB
(Haseloff et al., 2005). Astrocytes exchange inductive and regu-
latory substances with the cerebral endothelium (e.g., vascular
endothelial growth factor), which defines the structure of tight
junctions and the permeability of the BBB (Abbott, 2002; Fischer
et al., 2000). Consequently, astrocytic injurymay compromise the
selective transport through the BBB.
TNFα exerts its detrimental effects on the cerebral vasculature
through various mediators. A number of pathways have been
proposed, such as an enhanced synthesis of prostanoids and
expression of leukocyte adhesion molecules, an increased release
of nitric oxide (NO), and the expression of matrix metallopro-
teases (Mayhan, 2001). Among these mechanisms, increased
prostanoid synthesis and NO release have been identified as
potential mediators of TNFα-induced pial vasodilation (Brian and
Faraci, 1998; Mayhan, 1998; Shibata et al., 1996). A separate line
of research has also indicated that the TNFα-induced decrease in
transendothelial resistance at the BBB is prostanoid and NO-
dependent (de Vries et al., 1996; Hurst and Clark, 1997).
In the present study, we set out to determine both functional
(CBF) and pathomorphologic (BBB ultrastructure) cerebrovas-
cular parameters after the intracarotid infusion of TNFα in the rat
and to define whether NO is a common mediator of TNFα in the
regulation of the CBF and the breakdown of the BBB. Finally,
since the contribution of the astrocytic endfeet to the TNFα-
induced BBB disruption has received little attention, our ultra-
structural analysis focused on the characterization of the peri-
capillary astrocytic damage.
Materials and methods
The study was conducted in accordance with prevailing laws and regulations
on animal experiments and was approved by the ethical committee of the
University of Szeged, Hungary.
Assessment of CBF with laser-Doppler flowmetry
Twenty male Wistar rats (260–300 g) were anesthetized with 5% chloral
hydrate (40 mg/kg, i.p.), and the body temperature was kept at 37°C with a heating
pad. Anesthesia was maintained continuously up to the termination of the expe-
riment. The right femoral vein and the tail arterywere cannulated for the infusion of
solutions, and the recording of arterial blood pressure, respectively. Next, the
trachea was intubated, and the animals were ventilated with a small animal
respirator (SAR-830/P CWE Inc. U.S.A.). The right common carotid artery was
cannulated for the infusion of solutions. Finally, the animal's head was fixed in a
stereotaxic frame, the calvaria was exposed, and a circular craniotomy hole (1–
2 mm in diameter) was drilled above the ipsilateral, frontoparietal cortex (Bregma
0.20 mm, 1.5 mm lateral; Paxinos and Watson, 1986; Bari et al., 2000). The dura
mater was removed, and the CBF was monitored with a needle probe of a laser-
Doppler flowmeter (Periflux 4001, Sweden). The blood pressure and the laser
Doppler signal were stored on a PC for detailed analysis, which was performed by
means of the software Perisoft for Windows (Perimed, Sweden). The experiment
was terminated approximately 2.5 h later with an overdose of chloral hydrate.
After the surgical procedure, 10 animals were pretreated with the NO synthase
(NOS) inhibitor N(G)-nitro-L-arginine-methyl ester (L-NAME), at a dose of 20mg/
kg in 1 ml saline, given over 2 min (i.v.), while the other 10 rats were used ascontrols. Half of the animals from both groups received 2.5 μg/kg TNFα (human
recombinant, Sigma) in 1 ml saline at a speed of 0.1 ml/min into the right common
carotid artery (i.c.). The other half of the rats were infused with saline in a similar
fashion (i.c.) and served as controls. The concentration of TNFαwas chosen based
on our previous study, where 2.5 μg/kg TNFα given i.c. markedly disrupted the
BBB, but did not cause septic shock in rats (Farkas et al., 2003). Table 1 demons-
trates the final compositions of the experimental groups.
The experimental protocol of CBF measurement and the recording of mean
arterial pressure (MAP) were performed as follows (Fig. 1A). Baseline values were
assessed for 5 min immediately after the surgery (prior to the infusion of the solu-
tions). Next, L-NAMEwas administered into the femoral vein. Since L-NAMEcauses
a rapid increase in MAP, we waited for 15 min for the MAP to return to the baseline
before the i.c. administration of TNFα/saline. The CBF and MAP values were
repeatedly sampled at given timepoints (10, 20, 30, 40, 60 and90min) after the endof
the TNFα/saline infusion. Finally, the relative CBF values were expressed as
percentages of the baseline. The data were statistically analyzed with the repeated
measurement analysis of variance model (ANOVA) of the software SPSS.
Characterization of BBB morphology by electron microscopy
For electronmicroscopic analysis, another 50 rats (280–350 g) were operated
on in a similar fashion, except that the MAP and CBF were not monitored. In
accordance with the above experiment, an L-NAME solution (20mg/kg, i.v.) was
infused 15 min prior to the i.c. administration of TNFα (2.5 μg/kg) or saline. At
45 min, 4 h or 8 h with respect to the end of TNFα or saline infusion, the animals
were sacrificed by transcardial perfusion with saline followed by a solution of
2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer (PB,
pH 7.4) (Fig. 1B). The brains were removed and stored in a solution of 2.5%
glutaraldehyde and 2% paraformaldehyde in 0.1 M PB until further processing.
Table 1 demonstrates the various experimental groups.
Samples of the ipsilateral, frontoparietal cortex (Bregma 0.20 mm; Paxinos
and Watson, 1986) were prepared for electron microscopy (Farkas et al., 2003).
Briefly, tissue blocks were incubated in an aqueous solution of 1% OsO4 and 5%
K2Cr2O7 after thorough rinsing. Subsequently, the samples were dehydrated,
incubated in 1% uranylacetate, and embedded in Durcupan epoxy resin (Fluka).
Semi-thin sections in the coronal plane were cut on an ultramicrotome (Ultracut
E, Reichert-Jung) and stained on object glasses with a 1:1 mixture of 1%
methylene blue and 1% Azure II blue. The samples were then coverslipped with
DPX and analyzed under a light microscope (Nikon E600). Ultrathin sections
were cut from the same blocks and collected on 200-mesh copper grids. The
preparations were then contrasted with 5% uranylacetate and Reynolds
leadcitrate solution. Finally, the samples were analyzed with a Philips TM10
transmission electron microscope. Photographs were taken with a computer-
assisted digital camera (MegaView II, Soft Imaging Systems, Germany).
For quantitative analysis, approximately 0.12-mm2 of tissue surface was
scanned systematically through all cortical layers, and 25 ± 7 capillary cross-
Fig. 1. Experimental protocol for the measurement of cerebral blood flow (A) and the ultrastructural analysis of cortical capillaries (B). Abbreviations: i.c.: intracarotid,
i.v.: intravenous, L-NAME: N(G)-nitro-L-arginine-methyl ester.
Fig. 2. Cerebral blood flow and mean arterial pressure after TNFα and L-NAME
administration. Data are given asmean ± SEM. Significance values are defined as
P < 0.05*. *Significant difference between saline and TNFα alone. #Significant
difference between TNFα alone and TNFα+L-NAME. Abbreviations: CBF:
cerebral blood flow, L-NAME: N(G)-nitro-L-arginine-methyl ester, MAP: mean
arterial pressure.
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was measured with the software analySIS 3.2 (Soft Imaging Systems, Germany).
The diameter values were averaged for each rat, and this mean was used for
further statistical analysis. The capillaries displaying swollen astrocytic endfeet
were counted and the number was expressed as a percentage of the total number
of capillaries examined. The data were analyzed statistically with a two-way
ANOVA paradigm of the software SPSS.
Results
Cerebrocortical blood flow
As Fig. 2 demonstrates, TNFα infusion into the right common
carotid artery gradually elevated the CBF in the frontoparietal
cortex with respect to the baseline value (100%). Ten minutes
after the end of the TNFα infusion, the CBF had increased to
137%; it had reached a maximum of 190% by 60 min and arrived
at 182% by 90 min. At the same time, the CBF in the saline-
treated control group remained relatively constant. The elevation
of the CBF by TNFαwas significant as compared with the saline-
treated control group (P < 0.015*), specifically at 30, 40 and
60 min (Fig. 2). The MAP corresponding to the CBF data ranged
between 70 and 100 mmHg throughout the observation period,
and no statistical difference could be determined between the two
groups (P = 0.724).
The administration of L-NAME exerted no effect on the CBF
of the saline-infused control animals. However, the TNFα-
induced increase in CBFwas clearly prevented by L-NAME (P <
0.048*), particularly at 60 min (Fig. 2). L-NAME markedly
increased the MAP shortly after L-NAME administration (not
shown), but theMAP values gradually returned to a control levelof 72 ± 11 mmHg during 15 min (before the i.c. infusion of
TNFα or saline) and did not differ from the controls throughout
the period of recording (P = 0.485).
Fig. 3. Ultrastructural analysis of cortical capillaries. (A) Site of sampling. (B–F) Electron microscopic images of cortical capillary profiles. (G) Quantitative data on
pericapillary astrocytic swelling. (H) Lumen diameter of cortical capillaries. Data are given as mean ± SEM. Significance values are defined as P < 0.05*. *Indicates
TNFα vs. saline. Abbreviations: a: astrocytic endfoot, asterisk: capillary lumen, CPu: caudate putamen, ctx: cerebral cortex, e: endothelial cell, L-NAME: N(G)-nitro-
L-arginine-methyl ester LS: lateral septum, p: pericyte, VDB: ventral diagonal band.
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Semithin sections from the frontoparietal cortex exhibited
perivascular edema around the arterioles in the TNFα-treated ani-
mals. At an ultrastructural level, the examination of the micro-
vessels revealed two conspicuous abnormalities in the groups
treated with TNFα alone. First, the luminal endothelial surface
appeared to be irregular, displaying finger-like processes and
indentations and forming vacuoles (Fig. 3C). Second, the astrocytic
endfeet embracing the capillaries were considerably swollen as
shown by the noteworthy enlargement of the processes and their
low electron density (Figs. 3D and E). Finally, membranous inclu-
sions appeared in the cytoplasm of the endfeet, and the extensive
swelling occasionally distorted the capillary lumen (Fig. 3E).
Quantitative analysis revealed that the proportion of capillarieswith
astrocytic swelling had doubled 45 min after the TNFα infusion as
compared with the controls and demonstrated a further increase as
time progressed.At 8 h after the infusion, approximately 65%of the
investigated microvessels were affected. In contrast, the proportion
of capillaries with astrocytic swelling was reduced by L-NAME
from48% to 18%at 45min, from61% to 34%at 4 h, and from65%
to 51% at 8 h after TNFα infusion (Fig. 3G).
Although the diameter of the capillaries did not change accor-
ding to the statistical analysis, bothTNFα and L-NAMEdisplayeda tendency to decrease the vascular lumen diameter. At 45 min,
TNFα had reduced the lumen diameter from the control value of
4.56 μm to 4.08 μm, which decreased further to 3.86 μm at 4 h,
and to 3.61 μm at 8 h after the infusion. After treatment with L-
NAME alone or in combination with TNFα, the capillary lumen
diameter varied in the interval 3.51–3.99 μm, as opposed to
4.56 μm for the saline control group (Fig. 3H).
Discussion
Cerebrocortical blood flow
We demonstrated that TNFα administered into the common
carotid artery increased the CBF in the rat frontoparietal cortex.
The model used here simulates the cerebral effects of TNFα of
peripheral origin. Our data are in line with previous observations,
where TNFαwas superfused onto the rat or new-born piglet brain
surface in a cranial window, and a gradual, significant increase in
pial arteriolar diameter was measured up to 4 h after treatment
(Brian and Faraci, 1998; Shibata et al., 1996). In another set of
experiments involving the use of laser Doppler flowmetry, the
intracisternal injection of TNFα increased the CBF in the rat
parietal cortex up to 6 h in a dose- and time-dependent manner
(Angstwurm et al., 1998). The current results are complementary
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studies, TNFα stimulated the cerebral vessels form the perivas-
cular surface, while in our experiment, TNFα interacted with the
endothelium first, as it arrived from the luminal surface. Accor-
dingly, the different routes of TNFα administrationmay influence
the CBF via different cascades.
Two pathways have been suggested to mediate the effect of
TNFα in the above models. First, NO was implicated, because
topical administration of the NOS inhibitors N-nitro-L-arginine
and aminoguanidine blocked the TNFα-induced vasodilation in
the pial arterioles (Brian and Faraci, 1998; Shibata et al., 1996).
Second, prostanoids appeared to be potential mediators, because
the nonselective cyclooxygenase inhibitor indomethacin pre-
vented the pial vasodilation caused by TNFα (Shibata et al.,
1996). Our data accord with the first suggestion, since systemic
administration of the general NOS inhibitor L-NAME blocked
the TNFα-induced increase in CBF completely. The results here
also demonstrate that, in parallel with the TNFα-induced, NO-
related dilation of the pial arterioles (Brian and Faraci, 1998;
Shibata et al., 1996), the CBF (which reflects blood flow through
both the pial vessels and the cerebrocortical microvascular
network) increases in an NO-dependent manner.
The source of NO cannot be conclusively determined in our
present study, because a general NOS inhibitor was applied. In
previous experiments, inducible NOS (iNOS) was considered to
be themost likelyNOS isoform to generate NO in TNFα-exposed
pial arterioles (Brian and Faraci, 1998). The reason for this
suggestion was that the bacterial lipopolysaccharide and proin-
flammatory cytokines systemically stimulated the expression of
iNOS (Bredt, 1999; Ketteler et al., 1998; Parratt, 1998), and the
selective iNOS inhibitor aminoguanidine blocked lipopolysac-
charide- and TNFα-stimulated pial vasodilation (Brian and
Faraci, 1998; Mayhan, 1998; Shibata et al., 1996). In contrast,
several studies have provided experimental evidence for the
involvement of neuronal NOS (nNOS) in the regulation of the
CBF (Hagioka et al., 2005; Paul et al., 1997; Staunton et al.,
2000). Most relevant from the aspect of inflammatory mediators
is the finding that the pial arteriolar vasodilation is mediated by
nNOS (but not iNOS) in experimental pneumococcal meningitis,
as shown by the selective inhibition of NOS isoforms in rats (Paul
et al., 1997). As a third possibility, an elevated expression of
endothelial NOS (eNOS) was demonstrated in experimental
bacterial meningitis in mice and after injections of lipopolysac-
charide in rats (Iwase et al., 2000;Winkler et al., 2001). However,
increased eNOS expression in these models was suggested to
counteract the breaching of the BBB (Winkler et al., 2001), rather
than the elevation of CBF. Hence, it seems likely that, in addition
to iNOS, nNOS may also play a vasodilatory role in cerebral
inflammatory reactions, while eNOS is involved in the main-
tenance of BBB integrity.
Cerebrocortical capillary ultrastructure
The present ultrastructural analysis of the cerebrocortical
capillaries demonstrates that TNFα causes the swelling of the
pericapillary astrocytic endfeet. Further, the extent of TNFα-in-
duced astrocytic swelling is reduced by the general NOS inhibitorL-NAME. These data indicate that TNFα causes an NO-de-
pendent microvascular injury in the brain.
The harmful effect of TNFα on the BBB was previously indi-
cated by the extravasation of Evans blue and sodium fluorescein
into the brain tissue after an intra-arterial infusion of TNFα in
piglets (Abraham et al., 1996). Further, the i.c. administration of
TNFα also resulted in the transmigration of lymphocytes into the
brain parenchyma in rats (Farkas et al., 2003). All these in vivo
findings strongly suggest that TNFα disrupts the BBB.
Although the alterations caused by TNFα in endothelial trans-
portermolecules, adhesion proteins and intraendothelial signaling
pathways have been widely investigated (Lee and Kang, 2004;
Miller et al., 2005; Otto et al., 2000; Trickler et al., 2005), less is
known about the actual ultrastructural correlates of BBB disrup-
tion. In vitro studies have suggested that the TNFα-induced leak-
age of the BBB is caused by a robust increase in endothelial
transcytosis, or an elevated, paracellular permeability through
loosened tight junctions (Deli et al., 2005; Miller et al., 2005;
Wong et al., 2004). We report here that TNFα damages the astro-
cytic component of the BBB in the form of progressing swelling,
which may have serious consequences on the transport through
the barrier. The astrocytic endfeet are implicated in the induction
and the maintenance of the BBB (Abbott, 2002; Haseloff et al.,
2005). The maintenance of the adult BBB appears to be depen-
dent on the exchange of inductive signals between the endo-
thelium and the astrocytes (Abbott, 2002). For example, the
astrocytes are actively involved in the formation of tight junctions
(Tao-Cheng et al., 1987). Further, the vascular endothelial growth
factor-related BBB permeability seems to be determined by the
presence of astrocytes (Fischer et al., 2000). Thus, if the astrocytic
endfeet are swollen as shown here, the cross-talk with the endo-
thelium becomes disturbed or discontinues, which can lead to a
BBB dysfunction. In support of this view, the BBB disruption
indicated by the extravasation of Evans blue was associated with
astrocytic swelling that involved aquaporin-4, a major water
channel implicated in the formation of injury-related brain edema
(Venero et al., 2001; Vizuete et al., 1999).
Similarly to the TNFα-related regulation of the CBF, lipopoly-
saccharide- and TNFα-induced BBB damage can be mediated by
the prostanoid and the NO systems (Jaworowicz et al., 1998;
Mayhan, 2001). In an in vitro BBBmodel, TNFα rapidly reduced
the transendothelial resistance typical of the BBB, which was
prevented by the nonselective cyclooxygenase inhibitor indo-
methacin (de Vries et al., 1996). Likewise, the TNFα-related
reduction in transendothelial resistancewas partially prevented by
the general NOS inhibitor N-monomethyl-L-arginine (Hurst and
Clark, 1997).AnNO-related increase inBBBpermeability during
infections was indicated by the potentiating effect of L-arginine,
the substrate for NO production (Shukla et al., 1995). Further-
more, the involvement of NOS in BBB disruption was demons-
trated in experimental bacterial meningitis in iNOS-deficientmice
(Winkler et al., 2001). The present experiments provide additional
data on the role of NO in TNFα-induced BBB injury. The results
imply that NO produced in response to TNFα in the BBB micro-
environment plays a role in astrocytic injury, because the general
inhibition of NOS reduces the TNFα-related swelling of astrocy-
tic endfeet.
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signal transduction pathway in both endothelial cells and astro-
cytes (Sporbert et al., 1999). Moreover, peroxynitrite generated
from NO and superoxide has been suggested to elicit the dys-
function of the BBB by reducing the viability of endothelial cells
(Tan et al., 2004). Astrocytes appear to be relatively resistant to
peroxynitrite (Pehar et al., 2002). However, cGMP can activate
the expression of various aquaporins (water channels) (Boassa
and Yool, 2002; Ishikawa et al., 2002; Miyajima et al., 2004),
some of which have been identified in astrocytes and are
involved in injury-related edema formation in the brain (Leh-
mann et al., 2004; Venero et al., 2001). Accordingly, we
hypothesize that astrocytic swelling could possibly take place in
our model via a TNFα→NO→ cGMP→ aquaporin expression
pathway.
Summary
The novel findings of the present study can be summarized as
follows. We identified the astrocytic component of the BBB as a
vulnerable target for TNFα, which suggests that astrocytic injury
may play a role in TNFα-related BBB disruption. Further, the
two experimental approaches employed in the present study
have enabled us to observe the simultaneous action of TNFα on
functional and ultrastructural parameters of the cerebral micro-
vasculature. The experiments revealed that the effects of TNFα
on both the CBF and the BBB ultrastructure utilize at least one
identical mediator, NO, while prostanoids are assumed as addi-
tional candidates.
In conclusion, the deleterious effect of infections and inflam-
matory reactions on the cerebrovascular system may be counter-
acted by the inhibition of NO generation.
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